174 related articles for article (PubMed ID: 21316221)
1. Synthesis and SAR of novel quinazolines as potent and brain-penetrant c-jun N-terminal kinase (JNK) inhibitors.
He Y; Kamenecka TM; Shin Y; Song X; Jiang R; Noel R; Duckett D; Chen W; Ling YY; Cameron MD; Lin L; Khan S; Koenig M; LoGrasso PV
Bioorg Med Chem Lett; 2011 Mar; 21(6):1719-23. PubMed ID: 21316221
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, biological evaluation, and molecular modeling of 11H-indeno[1,2-b]quinoxalin-11-one derivatives and tryptanthrin-6-oxime as c-Jun N-terminal kinase inhibitors.
Schepetkin IA; Khlebnikov AI; Potapov AS; Kovrizhina AR; Matveevskaya VV; Belyanin ML; Atochin DN; Zanoza SO; Gaidarzhy NM; Lyakhov SA; Kirpotina LN; Quinn MT
Eur J Med Chem; 2019 Jan; 161():179-191. PubMed ID: 30347329
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and SAR of 2-phenoxypyridines as novel c-Jun N-terminal kinase inhibitors.
Song X; Chen W; Lin L; Ruiz CH; Cameron MD; Duckett DR; Kamenecka TM
Bioorg Med Chem Lett; 2011 Dec; 21(23):7072-5. PubMed ID: 22004719
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and SAR of 4-(pyrazol-3-yl)-pyridines as novel c-jun N-terminal kinase inhibitors.
Noël R; Shin Y; Song X; He Y; Koenig M; Chen W; Ling YY; Lin L; Ruiz CH; LoGrasso P; Cameron MD; Duckett DR; Kamenecka TM
Bioorg Med Chem Lett; 2011 May; 21(9):2732-5. PubMed ID: 21185177
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and SAR of novel isoxazoles as potent c-jun N-terminal kinase (JNK) inhibitors.
He Y; Duckett D; Chen W; Ling YY; Cameron MD; Lin L; Ruiz CH; Lograsso PV; Kamenecka TM; Koenig M
Bioorg Med Chem Lett; 2014 Jan; 24(1):161-4. PubMed ID: 24332487
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of 1-aryl-5-anilinoindazoles as c-Jun N-terminal kinase inhibitors.
Jiang R; Frackowiak B; Shin Y; Song X; Chen W; Lin L; Cameron MD; Duckett DR; Kamenecka TM
Bioorg Med Chem Lett; 2013 May; 23(9):2683-7. PubMed ID: 23518277
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological evaluation, X-ray structure, and pharmacokinetics of aminopyrimidine c-jun-N-terminal kinase (JNK) inhibitors.
Kamenecka T; Jiang R; Song X; Duckett D; Chen W; Ling YY; Habel J; Laughlin JD; Chambers J; Figuera-Losada M; Cameron MD; Lin L; Ruiz CH; LoGrasso PV
J Med Chem; 2010 Jan; 53(1):419-31. PubMed ID: 19947601
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and SAR of piperazine amides as novel c-jun N-terminal kinase (JNK) inhibitors.
Shin Y; Chen W; Habel J; Duckett D; Ling YY; Koenig M; He Y; Vojkovsky T; LoGrasso P; Kamenecka TM
Bioorg Med Chem Lett; 2009 Jun; 19(12):3344-7. PubMed ID: 19433357
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of quinazolines as tyrosine kinase inhibitors.
Srivastava SK; Kumar V; Agarwal SK; Mukherjee R; Burman AC
Anticancer Agents Med Chem; 2009 Mar; 9(3):246-75. PubMed ID: 19275520
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and SAR of 4-substituted-2-aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors.
Humphries PS; Lafontaine JA; Agree CS; Alexander D; Chen P; Do QQ; Li LY; Lunney EA; Rajapakse RJ; Siegel K; Timofeevski SL; Wang T; Wilhite DM
Bioorg Med Chem Lett; 2009 Apr; 19(8):2099-102. PubMed ID: 19327989
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 2-(5-nitrothiazol-2-ylthio)benzo[d]thiazoles as novel c-Jun N-terminal kinase inhibitors.
De SK; Chen LH; Stebbins JL; Machleidt T; Riel-Mehan M; Dahl R; Chen V; Yuan H; Barile E; Emdadi A; Murphy R; Pellecchia M
Bioorg Med Chem; 2009 Apr; 17(7):2712-7. PubMed ID: 19282190
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of brain penetrant selective JNK inhibitors with improved pharmacokinetic properties for the prevention of neurodegeneration.
Bowers S; Truong AP; Jeffrey Neitz R; Hom RK; Sealy JM; Probst GD; Quincy D; Peterson B; Chan W; Galemmo RA; Konradi AW; Sham HL; Tóth G; Pan H; Lin M; Yao N; Artis DR; Zhang H; Chen L; Dryer M; Samant B; Zmolek W; Wong K; Lorentzen C; Goldbach E; Tonn G; Quinn KP; Sauer JM; Wright S; Powell K; Ruslim L; Ren Z; Bard F; Yednock TA; Griswold-Prenner I
Bioorg Med Chem Lett; 2011 Sep; 21(18):5521-7. PubMed ID: 21813278
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and optimization of thiadiazole derivatives as a novel class of substrate competitive c-Jun N-terminal kinase inhibitors.
De SK; Chen V; Stebbins JL; Chen LH; Cellitti JF; Machleidt T; Barile E; Riel-Mehan M; Dahl R; Yang L; Emdadi A; Murphy R; Pellecchia M
Bioorg Med Chem; 2010 Jan; 18(2):590-6. PubMed ID: 20045647
[TBL] [Abstract][Full Text] [Related]
14. Identification of potent pyrazolo[4,3-h]quinazoline-3-carboxamides as multi-cyclin-dependent kinase inhibitors.
Traquandi G; Ciomei M; Ballinari D; Casale E; Colombo N; Croci V; Fiorentini F; Isacchi A; Longo A; Mercurio C; Panzeri A; Pastori W; Pevarello P; Volpi D; Roussel P; Vulpetti A; Brasca MG
J Med Chem; 2010 Mar; 53(5):2171-87. PubMed ID: 20141146
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of disubstituted thiophene and thiazole based inhibitors of JNK.
Hom RK; Bowers S; Sealy JM; Truong AP; Probst GD; Neitzel ML; Neitz RJ; Fang L; Brogley L; Wu J; Konradi AW; Sham HL; Tóth G; Pan H; Yao N; Artis DR; Quinn K; Sauer JM; Powell K; Ren Z; Bard F; Yednock TA; Griswold-Prenner I
Bioorg Med Chem Lett; 2010 Dec; 20(24):7303-7. PubMed ID: 21071223
[TBL] [Abstract][Full Text] [Related]
16. Development of amino-pyrimidine inhibitors of c-Jun N-terminal kinase (JNK): kinase profiling guided optimization of a 1,2,3-benzotriazole lead.
Palmer WS; Alam M; Arzeno HB; Chang KC; Dunn JP; Goldstein DM; Gong L; Goyal B; Hermann JC; Hogg JH; Hsieh G; Jahangir A; Janson C; Jin S; Ursula Kammlott R; Kuglstatter A; Lukacs C; Michoud C; Niu L; Reuter DC; Shao A; Silva T; Trejo-Martin TA; Stein K; Tan YC; Tivitmahaisoon P; Tran P; Wagner P; Weller P; Wu SY
Bioorg Med Chem Lett; 2013 Mar; 23(5):1486-92. PubMed ID: 23352510
[TBL] [Abstract][Full Text] [Related]
17. Pyrazole derivatives as potent inhibitors of c-Jun N-terminal kinase: synthesis and SAR studies.
Doma A; Kulkarni R; Palakodety R; Sastry GN; Sridhara J; Garlapati A
Bioorg Med Chem; 2014 Nov; 22(21):6209-19. PubMed ID: 25261929
[TBL] [Abstract][Full Text] [Related]
18. Discovery of the c-Jun N-Terminal Kinase Inhibitor
Nagy MA; Hilgraf R; Mortensen DS; Elsner J; Norris S; Tikhe J; Yoon W; Paisner D; Delgado M; Erdman P; Haelewyn J; Khambatta G; Xu L; Romanow WJ; Condroski K; Bahmanyar S; McCarrick M; Benish B; Blease K; LeBrun L; Moghaddam MF; Apuy J; Canan SS; Bennett BL; Satoh Y
J Med Chem; 2021 Dec; 64(24):18193-18208. PubMed ID: 34894681
[TBL] [Abstract][Full Text] [Related]
19. Development of indole/indazole-aminopyrimidines as inhibitors of c-Jun N-terminal kinase (JNK): optimization for JNK potency and physicochemical properties.
Gong L; Han X; Silva T; Tan YC; Goyal B; Tivitmahaisoon P; Trejo A; Palmer W; Hogg H; Jahagir A; Alam M; Wagner P; Stein K; Filonova L; Loe B; Makra F; Rotstein D; Rapatova L; Dunn J; Zuo F; Dal Porto J; Wong B; Jin S; Chang A; Tran P; Hsieh G; Niu L; Shao A; Reuter D; Hermann J; Kuglstatter A; Goldstein D
Bioorg Med Chem Lett; 2013 Jun; 23(12):3565-9. PubMed ID: 23664880
[TBL] [Abstract][Full Text] [Related]
20. Novel quinazoline derivatives bearing various 6-benzamide moieties as highly selective and potent EGFR inhibitors.
Hou W; Ren Y; Zhang Z; Sun H; Ma Y; Yan B
Bioorg Med Chem; 2018 May; 26(8):1740-1750. PubMed ID: 29523467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]